1-4 of 4
Rasmus Froberg Brøndum
Close
Sort by
Journal Articles

CDCA2 Is a Predictive Marker and Mediator of Bortezomib Response in Diffuse Large B-Cell Lymphoma

Hanne Due, Issa Ismail Issa, Martin Thomsen, Maja Zimmer Jakobsen, Hulda Haraldsdóttir, Rasmus Froberg Brøndum, Karen Dybkaer
Journal: Blood
Blood (2023) 142 (Supplement 1): 1617.
https://doi.org/10.1182/blood-2023-173803
Published: 2023
Journal Articles

Addition of Drug-Response Specific Micro-RNAs to the International Prognostic Index Improves Prognostic Stratification of GCB-DLBCL Patients Treated with R-CHOP

Karen Dybkær, PhD, Hanne Due, MSc, Rasmus Froberg Brøndum, PhD, Ken H. Young, MD PhD, Martin Bøgsted, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1623.
https://doi.org/10.1182/blood-2019-122351
Published: 2019
Journal Articles

B-Cell Differentiation Dependent Classification of Diffuse Large B-Cell Lymphoma By the Nanostring Technology

Thomas Yssing Michaelsen, BS, Rasmus Froberg Brøndum, Senior Bioinformatician, Julia Richter, PhD, Wolfram Klapper, MD, Mads Albertsen, Associate Professor, Hans Erik Johnsen, MD Professor, Karen Dybkær, Professor, Tarec Christoffer El-Galaly, MD PhD, Martin Bøgsted, Professor
Journal: Blood
Blood (2017) 130 (Supplement 1): 3995.
https://doi.org/10.1182/blood.V130.Suppl_1.3995.3995
Published: 2017
Journal Articles

Acute Myeloid Leukemia Classification System That Associates Normal Myeloid-Cell Subset Gene Signatures with Prognosis

Anna Amanda Schönherz, PhD, Julie Støve Bødker, PhD, Alexander Schmitz, Rasmus Froberg Brøndum, Senior Bioinformatician, Lasse Hjort Jakobsen, MSc, Marianne Tang Severinsen, MD PhD, Tarec Christoffer El-Galaly, MD PhD, Karen Dybkær, Professor, Martin Bøgsted, Professor, Hans Erik Johnsen, MD Professor
Journal: Blood
Blood (2017) 130 (Supplement 1): 2689.
https://doi.org/10.1182/blood.V130.Suppl_1.2689.2689
Published: 2017